The probiotic E. coli Nissle 1917 was engineered to enable stable and antibiotic free protein expression platforms using native plasmids. Further modification aids in the production of high‐level protein expression for antimicrobial secretion whose activity is comparable to industry standard E. coli BL21.
Halimatun Sakdiah Zainuddin +2 more
wiley +1 more source
Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI®induces enhanced serological, cellular and protective immune responses [PDF]
Weiping Cao +8 more
openalex +1 more source
Cathepsin B‐sensitive peptide–adjuvant conjugates are designed, synthesized, and evaluated to deliver an antigenic peptid and an adjuvant targeting Toll‐like receptors 7 and 8 (TLR7/8) to antigen presenting cells. The adjuvant is released by cathepsin B resulting in antigen presentation and TLR mediated T cell activation.
Marjolein M. E. Isendoorn +6 more
wiley +1 more source
Safety, immunogenicity and efficacy of influenza vaccine in children [PDF]
Otávio Cintra, Luís Rey
openalex +1 more source
Abstract As one of the most important components of foods, animal meat provides a lot of protein, fat, and energy for humans. However, nutrition and health of animals directly affect the healthiness of human, especially antibiotic residues in animals induced by abuse of antibiotics.
Zichao Wang +8 more
wiley +1 more source
Incidence of live-attenuated influenza vaccine administration beyond expiry date in children and adolescents aged 2–17 years in the UK: a population-based cohort study [PDF]
Hervé Caspard +3 more
openalex +1 more source
P-594. Temperature Stability of BPL-1357, a BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine [PDF]
Camellia Banerjee +4 more
openalex +1 more source
Effectiveness of influenza vaccines in Italy in the 2024/25 season: A nationwide, test-negative design study based on surveillance records. [PDF]
Daniel Cifo +12 more
openalex +1 more source
811 Dermal Fillers and Delayed Hypersensitivity Following Influenza Vaccine: A Case Report [PDF]
Henry Magill +2 more
openalex +1 more source
Abstract Background Respiratory syncytial virus (RSV) is a leading cause of hospitalization and mortality in early infancy. Maternal immunization offers a preventive strategy, but uncertainties regarding safety and economic value have limited its implementation.
Johnatan Torres‐Torres +10 more
wiley +1 more source

